There is a growing body of evidence suggesting that metformin is able to initiate p53 by both“AMPK-dependent”[8,14] and -independent [17,40] mechanisms to stimulate apoptosis and cell cycle arrest and hence might be essential for cancer therapy. This evidence concerns the gene PRKAA1 and cancer.